Cue Biopharma, Inc. Total Assets
Cue Biopharma, Inc. (CUE) had Total Assets of $30.71 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-14
- 2026-06-30: Assets $30.71M.
- 2026-03-31: Assets $30.88M.
- 2025-12-31: Assets $42.21M.
- 2025-09-30: Assets $31.64M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $30.71M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $30.88M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $42.21M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $31.64M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $40.71M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $22.25M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $32.19M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $44.81M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $42.33M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $53.95M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $61.53M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $68.89M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $73.16M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $81.68M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $91.28M 10-K · filed 2024-03-28 | $91.28M 10-K · filed 2023-03-21 |
| 2022-09-30 | $76.30M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $84.75M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $90.70M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $83.40M 10-K · filed 2023-03-21 | |
| 2021-09-30 | $78.88M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $89.67M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $88.72M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $99.53M 10-K · filed 2022-03-16 | |
| 2020-09-30 | $106.62M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $101.35M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $60.65M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $71.61M 10-K · filed 2021-03-09 | |
| 2019-09-30 | $45.21M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $41.76M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $45.19M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $45.36M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $44.58M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $53.11M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $59.33M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $66.95M 10-K · filed 2019-03-14 | $66.95M 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |